We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Genomic Study Links Potassium Levels to Regulation of BP

By LabMedica International staff writers
Posted on 04 Jan 2018
Print article
A recent paper described a study designed to examine different points of the human genome to determine where the genetic sequence linked serum potassium levels to modulation of blood pressure (BP).

Investigators at the University of Georgia (Athens, USA) performed genome-wide analyses to identify genomic loci that interacted with potassium to influence BP using single-marker and gene-based tests on Chinese participants of the GenSalt study (Genetic Epidemiology Network of Salt Sensitivity).

The initial GenSalt study, which was designed to evaluate gene-diet (sodium and potassium) interactions on BP regulation, was performed in rural areas in northern China from October 2003 to July 2005. The overall objective of the study was to identify susceptibility genes that influenced individual BP responses to dietary sodium and potassium intake in human populations. The specific aims were: (1) To localize and identify novel genes related to variation in BP responses to a low dietary sodium intake and a high dietary sodium intake; (2) To localize and identify novel genes related to variations in BP responses to oral potassium supplementation; and (3) To localize and identify novel genes related to BP responses to a cold pressor test. In addition, the GenSalt study localized and identified genes related to usual BP level and the risk of hypertension.

For the current study, the investigators analyzed data from1876 GenSalt participants. The average results of three urine samples were used to estimate potassium excretion, while nine BP measurements were taken using a random-zero sphygmomanometer. A total of 2.2 million single nucleotide polymorphisms were imputed using Affymetrix (Santa Clara, CA, USA) 6.0 genotype data and the Chinese Han of Beijing and Japanese of Tokyo HapMap reference panels.

Results published in the December 6, 2017, online edition of the journal Circulation: Cardiovascular Genetics revealed two genomic loci - one of which had never been identified - and six individual genes, all significantly associated with the regulation of blood pressure in the body.

“One of the major drawbacks of previous genetic studies of hypertension is that these studies did not explore the interactions between genes and environmental factors,” said senior author Dr. Changwei Li, assistant professor of biostatistics and epidemiology at the University of Georgia. “For example, some genes’ effect on blood pressure only manifests under certain environments. If environmental factors are not taken into account, these genes will not be identified for hypertension.”

“Findings from our study help to identify individuals who are particularly sensitive to dietary potassium as a way to reduce blood pressure, based on their genomic profiles,” said Dr. Li. “Subsequently, we could provide personalized suggestions to prevent disease based on their genotypes.”

Related Links:
University of Georgia
Affymetrix

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Blood Gas and Chemistry Analysis System
Edan i500
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay

Print article

Channels

Clinical Chemistry

view channel
Image: A one-step confirmatory laboratory test could definitively diagnose active syphilis infection within 10 minutes (Photo courtesy of Adobe Stock)

First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes

In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more